UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

PSA testing: an evolving relationship with prostate cancer screening

Constantinou, J; Feneley, MR; (2006) PSA testing: an evolving relationship with prostate cancer screening. PROSTATE CANCER P D , 9 (1) 6 - 13. 10.1038/sj.pcan.4500838.

Full text not available from this repository.

Abstract

PSA testing has made prostate cancer screening a reality for men in many parts of the world, but its benefit for men's health continues to be debated. In men exposed to PSA testing, there has been a well-documented change in the presentation of prostate cancer with a shift towards earlier pathological stage, not without justifiable concern about over-diagnosis by prostate biopsy. Increasingly, men now diagnosed with early stage cancer have previous PSA exposure and are selected for biopsy based on PSA change in relation to cutoff values. Some recent observations suggest that PSA may no longer be an effective marker for early stage tumours, with PSA elevation failing to discriminate tumour-specific characteristics from benign gland enlargement. Traditionally, variation in pathological stage of clinically localised prostate cancer at diagnosis has related to clinical stage, PSA and biopsy Gleason grade, but with distinctions based upon these three assessments declining and an increasing proportion of organ-confined tumours at presentation, new methods of cancer detection and prognostic assessment are now required. Molecular technologies hold great promise in this respect, and in the future biomarker signatures are likely to overshadow total PSA for guiding early diagnosis and prognostic assessment. While arguments about prostate screening will continue, owing not least to its feasibility, future debate is likely to focus increasingly on technological advances and molecular profiling of these notoriously heterogeneous tumours.

Type: Article
Title: PSA testing: an evolving relationship with prostate cancer screening
DOI: 10.1038/sj.pcan.4500838
Keywords: prostate-specific antigen, screening, case-finding, prostate cancer, RADICAL RETROPUBIC PROSTATECTOMY, PREDICT PATHOLOGICAL STAGE, CLINICAL STAGE, GLEASON SCORE, ANTIGEN, TRIAL, MEN, UPDATE, TUMOR, RECURRENCE
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci > Department of Targeted Intervention
URI: http://discovery.ucl.ac.uk/id/eprint/184242
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item